Researchers isolate DNA from a 170,000-year-old Neanderthal skeleton.
QDx will develop, market, and process the QPredict Prostate Mitomic Test, which will be based on Mitomics' flagship mitochondrial DNA-based prostate cancer diagnostic.
A new grant program aims to fund research that will study mitochondrial genomes for their potential uses in diagnosing, identifying, and monitoring cancer.
The institute seeks to fund researchers who will study biomarkers that could detect mitochondrial dysfunction and its links to environmental stressors and exposures.
Mitomics, formerly called Genesis Genomics, is set to launch its first mitochondrial genomics-based test, for prostate cancer as it moves from an R&D shop to a commercial entity.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.